A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)

NCT04724109 · clinicaltrials.gov ↗

COMPLETED

Status

1088

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Equfina

Sponsor

Eisai Co., Ltd.